STF083010, an IRE1α RNase inhibitor, could impair PD1 expression in CD8+ T cells by inhibiting the transcriptional activity of XBP1 and enhancing the antitumour immunity of CD8+ T cells in mouse models of melanoma [176]. This evidence concerns the gene XBP1 and melanoma.